Newborn and Infant Nursing Reviews
Volume 8, Issue 1 , Pages e11-e19 , March 2008

FISH Diagnosis of 22q11.2 Deletion Syndrome

  • Kimberley A. Miller, MSN, RNC, NNP

      Affiliations

    • Corresponding Author InformationAddress correspondence to Kimberley A. Miller, 11134 Round Mountain Drive, Frisco, TX 75035.

References 

  1. Botto LD, May K, Fernhoff PM, et al. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics. 2003;112:101–107
  2. Burke W. Genetic testing. N Engl J Med. 2002;347:1867–1875
  3. Carlson C, Sirotkin H, Pandita R. Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am J Hum Genet. 1997;61:620–629
  4. Crifasi PA, Michels VV, Driscoll DJ, et al. DNA fluorescent probes for diagnosis of velocardiofacial and related syndromes. Mayo Clin Proc. 1995;70:1148–1153
  5. Donnenfeld AE, Cutillo D, Horwitz J, Knops J. Prospective study of 22q11 deletion analysis in fetuses with excess nuchal translucency. Am J Obstet Gynecol. 2006;194:508–511
  6. Edelmann L, Pandita RK, Spiteri E, et al. A common molecular basis for rearrangement disorders on chromosome 22q11. Hum Mol Genet. 1999;8:1157–1167
  7. Fokstuen S, Arbenz U, Artan S, et al. 22q11.2 deletions in a series of patients with non-selective congenital heart defects: incidence, type of defects and parental origin. Clin Genet. 1998;53:63–69
  8. Genetics home reference: your guide to understanding genetic conditions (22q11.2 deletion syndrome). 2006;Available at: http://ghr.nlm.nih.gov/condition=22q12deletionsyndrome[Retrieved June 17, 2006]
  9. Goldmuntz E, Emanuel BS. Genetic disorders of cardiac morphogenesis: the DiGeorge and velocardiofacial syndromes. Circ Res. 1997;80:437–443
  10. Gong W, Emanuel BS, Collins J, et al. A transcription map of the DiGeorge and velo-cardio-facial syndrome minimal critical region on 22q11. Hum Mol Genet. 1996;5:789–800
  11. Katzman PJ, Wang B, Sawhney M, Wang N. Differential detection of deletion 22q11.2 syndrome by specialty and indication. Pediatr Dev Pathol. 2005;8:557–567
  12. Larson RS, Butler MG. Use of fluorescence in situ hybridization (FISH) in the diagnosis of DiGeorge sequence and related diseases. Diagn Mol Pathol. 1995;4:274–278
  13. Levy-Mozziconacci A, Piquet C, Heurtevin P, Philip N. Prenatal diagnosis of 22q11 microdeletion. Prenat Diagn. 1997;17:1033–1037
  14. Lindsay EA, Rizzu P, Antonacci R, et al. A transcription map in the CATCH22 critical region: identification, mapping, and ordering of four novel transcripts expressed in heart. Genomics. 1996;32:104–112
  15. McDonald-McGinn DM, Emanuel BS, Zackai EH. 22q11.2 deletion syndrome. 2005;(Original work published 1999) Available at: www.geneclinics.org[Retrieved June 17, 2006]
  16. McDonald-McGinn DM, Tonnesen MK, Laufer-Cahana A, et al. Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net. Genet Med. 2001;3:23–29
  17. Moore JW, Binder GA, Berry R. Prenatal diagnosis of aneuploidy and deletion 22q11.2 in fetuses with ultrasound detection of cardiac defects. Am J Obstet Gynecol. 2004;191:2068–2073
  18. Portnoi M, Lebas F, Gruchy N, et al. 22q11.2 duplication syndrome: two new familial cases with some overlapping features with DiGeorge/velocardiofacial syndromes. Am J Med Genet. 2005;137A:47–51
  19. Robin NH, Shprintzen RJ. Defining the clinical spectrum of deletion 22q11.2. J Pediatr. 2005;147:90–96
  20. Saitta SC, Harris SE, Gaeth AP, et al. Aberrant interchromosomal exchanges are the predominant cause of the 22q11.2 deletion. Hum Mol Genet. 2004;13:417–428
  21. Shooner KA, Rope AF, Hopkin RJ, et al. Genetic analyses in two extended families with deletion of 22q11 syndrome: importance of extracardiac manifestations. J Pediatr. 2005;146:382–387
  22. Thomas JA, Graham JM. Chromosomes 22q11 deletion syndrome: an update and review for the primary pediatrician. Clin Pediatr. 1997;36:253–266
  23. Towbin JA, Casey B, Belmont J. Human genetics '99: the cardiovascular system (the molecular basis of vascular disorders). Am J Hum Genet. 1999;64:678–684
  24. Tsui KM, Ng YY, Yu WL, Lam TS. The use of fluorescence in situ hybridization in the diagnosis of DiGeorge anomaly. Hong Kong Med J. 1995;1:263–265
  25. Yakut T, Kilic SS, Cil E, et al. FISH investigation of 22q11.2 deletion in patients with immunodeficiency and/or cardiac abnormalities. Pediatr Surg Int. 2006;22:380–383
  26. Desmaze C, Scambler P, Prieur M, et al. Routine diagnosis of DiGeorge syndrome by fluorescent in situ hybridization. Hum Genet. 1993;90:663–665
  27. Driscoll DA, Budarf ML, Emanuel BS. A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11. Am J Hum Genet. 1992;50:924–933
  28. Driscoll DA, Salvink J, Sellinger B, et al. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counseling and prenatal diagnosis. J Med Genet. 1993;30:813–817
  29. Iwarsson E, Ahrlund-Richter L, Inzunza J, et al. Preimplantation genetic diagnosis of DiGeorge syndrome. Mol Hum Reprod. 1998;4:871–875
  30. Jaquez M, Driscoll DA, Li M. Unbalanced 15;22 translocation in a patient with manifestations of DiGeorge and velocardiofacial syndrome. Am J Med Genet. 1997;70:6–10
  31. Levy-Mozziconacci A, Wernert F, Scambler P, et al. Clinical and molecular study of DiGeorge sequence. Eur J Pediatr. 1994;153:813–820
  32. Fernandez L, Lapunzina P, Arjona D, et al. Comparative study of three diagnostic approaches (FISH, STRs and MLPA) in 30 patients with 22q11.2 deletion syndrome. Clin Genet. 2005;68:373–378
  33. Rauch A, Zink S, Zweier C, et al. Systematic assessment of atypical deletions reveals genotype-phenotype correlation in 22q11.2. J Med Genet. 2005;42:871–876
  34. Levy A, Demczuk S, Aurias A, et al. Interstitial 22q11 microdeletion excluding the ADU breakpoint in a patient with DiGeorge syndrome. Hum Mol Genet. 1995;2417–2419
  35. McQuade L, Christodoulou J, Budarf M, et al. Patient with a 22q11.2 deletion with no overlap of the minimal DiGeorge syndrome critical region (MDGCR). Am J Med Genet. 1999;86:27–33
  36. O'Donnell H, McKeown C, Gould C, et al. Detection of an atypical 22q11 deletion that has no overlap with the DiGeorge syndrome critical region. Am J Hum Genet. 1997;60:1544–1548
  37. Ligon AH, Beaudet AL, Shaffer LG. Simultaneous, multilocus FISH analysis for detection of microdeletions in the diagnostic evaluation of developmental delay and mental retardation. Am J Hum Genet. 1997;61:51–59
  38. Weksberg R, Hughes S, Moldovan L, et al. A method for accurate detection of genomic microdeletions using real-time quantitative PCR. BMC Genomics. 2005;6:1–10
  39. DeBerardinis RJ, Medne L, Spinner NB, Zackai EH. DiGeorge anomaly in a patient with isochromosome 18p born to a diabetic mother. Am J Med Genet. 2005;138A:155–159
  40. Goldmuntz E, Driscoll D, Budarf ML, et al. Microdeletions of chromosomal region 22q11 in patients with congenital conotruncal cardiac defects. J Med Genet. 1993;30:807–812
  41. Perez E, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes). Curr Opin Pediatr. 2002;14:678–683
  42. Matsuoka R, Kimura M, Scambler PJ, et al. Molecular and clinical study of 183 patients with conotruncal anomaly face syndrome. Hum Genet. 1998;70–80
  43. Moeschler JB, Shevell M and the Committee on Genetics. Clinical genetic evaluation of the child with mental retardation or developmental delays. Pediatrics. 2006;117:2304–2316
  44. Carter NP. Fluorescence in situ hybridization: state of the art. Bioimaging. 1996;4:41–51
  45. Hoovers JM. Fluorescence in situ hybridization in the study of chromosomal abnormalities. [Article in Dutch] Ned Tijdschr Geneeskd. 1999;143:2265–2268
  46. Raff R, Schwanitz G. Fluorescence in situ hybridization: general principles and clinical application with special emphasis to interphase diagnostics. Indian J Hum Genet. 2001;1:65–75
  47. Waters JJ. Demystified...FISH. J Clin Pathol Mol Pathol. 1998;51:62–70
  48. Oostlander AE, Meijer GA, Ylstra B. Microarray-based comparative genomic hybridization and its applications in human genetics. Clin Genet. 2004;66:488–495
  49. Driscoll DA. Prenatal diagnosis of the 22q11.2 deletion syndrome. Genet Med. 2001;3:14–18
  50. Assche EV, Staessen C, Vegetti W, et al. Preimplantation genetic diagnosis and sperm analysis by fluorescence in-situ hybridization for the most common reciprocal translocation t(11;22). Mol Hum Reprod. 1999;5:682–690
  51. Sermon K, Van Steirteghem A, Liebaers I. Preimplantation genetic diagnosis. Lancet. 2004;363:1633–1641
  52. Jalal SM, Law ME, Carlson RO, Dewald GW. Prenatal detection of aneuploidy by directly labeled multicolored probes and interphase fluorescence in situ hybridization. Mayo Clin Proc. 1998;73:132–137
  53. Miranda RN, Mark HF, Medeiros LJ. Fluorescent in situ hybridization in routinely processed bone marrow aspirate clot and core biopsy sections. Am J Pathol. 1994;145:1309–1314
  54. Rickman L, Fiegler H, Shaw-Smith C, et al. Prenatal detection of unbalanced chromosomal rearrangements by array CGH. J Med Genet. 2006;43:353–361
  55. Berend SA, Spikes AS, Kashork CD, et al. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci. Am J Med Genet. 2000;91:313–317
  56. Demczuk S, Desmaze C, Aikem M, et al. Molecular cytogenetic analysis of a series of 23 DiGeorge syndrome patients by fluorescence in situ hybridization. Ann Genet. 1994;37:60–65
  57. Le Caignec C, Boceno M, Saugier-Veber P, et al. Detection of genomic imbalances by array based comparative genomic hybridisation in fetuses with multiple malformations. J Med Genet. 2005;42:121–128
  58. Schoumans J, Ruivenkamp C, Holmber E, et al. Detection of chromosomal imbalances in children with idiopathic mental retardation by array based comparative genomic hybridisation (array-CGH). J Med Genet. 2005;42:699–705
  59. Emanuel BS, McDonald-McGinn D, Saitta SD, Zackai EH. The 22q11.2 deletion syndrome. Adv Pediatr. 2001;48:39–73
  60. Yamagishi H. The 22q11.2 deletion syndrome. Keio J Med. 2002;51:77–88

PII: S1527-3369(07)00186-9

doi: 10.1053/j.nainr.2007.12.006

Newborn and Infant Nursing Reviews
Volume 8, Issue 1 , Pages e11-e19 , March 2008

Article Tools